StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GRPM.JK$226.00+9.71%
Fair $226.00+0.0%

GRPM.JK

PT Graha Prima Mentari Tbk

Consumer Defensive / Beverages - Non-AlcoholicJakartaID

$226.00

+20.00 (+9.71%)

Fairly Valued+0.0%Fair Value $226.00Fund rank 26/100 · Data gapFallback financials|
SA 45/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-22.8B · quality 51.3/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: eodhdPeriods: 4Warnings: 1eodhd: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.2%, below the 5% threshold
Thesis & Journal · GRPM.JKLocal privado en este navegador · PT Graha Prima Mentari Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$350.1B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

4.2%

↓

Gross Margin

7.5%

↓

Debt/Equity

0.00

↓
52-Week Range$226
$45$525

TradingView lightweight chart

GRPM.JK price, volumen y niveles de valoración

Último $226.00Periodo +109.3%
Fair value: $226.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+32.3%

FCF CAGR

—

FCF margin

-3.9%

FCF / Net income

-9.59x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $754.44B · net income $3.04B · FCF $-29.12B

2022-FY → 2025-FY

Gross margin

7.5%+0.3% pts

Operating margin

1.0%+0.1% pts

Net margin

0.4%-0.3% pts

FCF margin

-3.9%-5.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$754.44B$754.44B$705.51B$306.18B$325.98B
Net Income$3.04B$3.04B$2.56B$4.44B$2.26B
EPS1.971.971.662.881.47
Gross Margin7.5%7.5%7.7%9.3%7.1%
Operating Margin1.0%1.0%0.9%1.7%0.9%
Net Margin0.4%0.4%0.4%1.5%0.7%
Balance Sheet
Debt/Equity0.000.000.000.000.00
Current Ratio1.531.531.4948.682.40
Cash Flow
Free Cash Flow$-29.12B$-29.12B$-22.82B$-11.76B$3.75B
Returns
ROE4.2%4.2%3.6%6.3%7.3%
Growth & Yield
Revenue Growth6.9%6.9%130.4%-6.1%—
EPS Growth18.7%18.7%-42.4%96.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

116.9%

muy exigente

EPS terminal req.

$20.05

Spread vs growth

-98.2%

5Y implied EPS CAGR

65.3%

muy exigente

EPS terminal req.

$24.27

Spread vs growth

-46.6%

10Y implied EPS CAGR

34.8%

muy exigente

EPS terminal req.

$39.08

Spread vs growth

-16.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +326.4%

Total return

+326.4%

Start / end P/E

32.0x → 115.0x

EPS bridge

1.66 → 1.97

Residual

+48.5%

EPS growth+18.7%
Multiple rerating+259.2%
Dividend+0.0%
Residual / FX / buybacks / cross-term+48.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.